Organic Catatonia Secondary to Central Nervous Infection : An Evidence Based Case Report
DOI:
https://doi.org/10.36408/mhjcm.v13i2.1469Keywords:
organic catatonia, meningitis, encephalitis, infection, treatmentAbstract
Background: Organic catatonia has been associated with various infectious etiologies, particularly central nervous system infections. While benzodiazepines and electroconvulsive therapy (ECT) are the most extensively studied treatments, accurate identification and targeted management of the underlying cause remain essential for effective treatment
Aims : evaluating evidence-based therapeutic strategies for the management of organic catatonia in patients with infections.
Method : Electronic Data Based was conducted using PubMed, ScienceDirect, Google Scholar, Cochrane, and Proquest. Eligible studies published between 2015 and 2025 included randomized controlled trials, systematic reviews, and case reports or case series focusing on the treatment of organic catatonia associated with central nervous system infections. Literature reviews, abstracts, non-English publications, and studies not aligned with the predefined PICO were excluded. Selected articles were critically appraised using the Joanna Briggs Institute (JBI) Critical Appraisal tools.
Results : 458 articles was identified, two studies (case series and case report) met the inclusion criteria. Abhijita et al. emphasized evidence-based management of organic catatonia secondary to meningitis (treated with ceftriaxone, doxycycline, lorazepam, and olanzapine, in addition to electroconvulsive therapy), while Doval et al. highlighted key diagnostic and therapeutic considerations in organic catatonia following encephalitis (treated with haloperidol, promethazine, lorazepam, amantadine, and escitalopram). Overall, these case reports offer valuable clinical insights.
Conclusion : Alongside infection-directed therapy, early recognition and timely pharmacological management of organic catatonia are essential for achieving optimal clinical outcomes.
Downloads
References
1. Iyer V, Spurling BC, Rizvi A. Catatonia. StatPearls. 2025 Dec 13;
2. Rogers JP, Oldham MA, Fricchione G, Northoff G, Ellen Wilson J, Mann SC, et al. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2023 Apr 11;37(4):327–69.
3. Khan FA, Khan MIA, Alnaher S, Zeshan M. Catatonia: Current Perspectives on Pathophysiology, Clinical Features, and Therapeutic Strategies. Journal of Medicine, Nursing and Public Health. 2024 Sep 2;7(2):79–91. doi:10.53819/81018102t7027.
4. Oldham MA. The Probability That Catatonia in the Hospital has a Medical Cause and the Relative Proportions of Its Causes: A Systematic Review. Psychosomatics. 2018 Jul;59(4):333–40.
5. Rogers JP, Wilson JE, Oldham MA. Catatonia in ICD-11. BMC Psychiatry. 2025 Apr 18;25(1):405. doi:10.1186/s12888-025-06857-6
6. Pelzer A, van der Heijden F, den Boer E. Systematic review of catatonia treatment. Neuropsychiatr Dis Treat. 2018 Jan;Volume 14:317–26.
7. Abhijita B, Kathatharan S, Sungoh D, Mynampally K, Bharadwaj B. Difficult to Treat Catatonia: A Case Series. Indian J Psychol Med. 2025 Nov 4;
8. Doval N, Kar S, Malhotra H. Unfolding the mystery: Rare presentation of Japanese encephalitis as catatonia. Int J Nutr Pharmacol Neurol Dis. 2015;5(4):159.
9. Edinoff AN, Kaufman SE, Hollier JW, Virgen CG, Karam CA, Malone GW, et al. Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges. Neurol Int. 2021 Nov 8;13(4):570–86.
10. de Jaime Ruiz P, García-Fogeda Romero JL, Gutiérrez-Rojas L. Catatonia and Mutism: Neurotic, Psychotic, or Organic Disorder? Case Rep Psychiatry. 2021 Oct 28;2021:1–5.
11. Vaidya BP, Purohith AN, Vaidyanathan S, Praharaj SK. Clinical Profile, Course, and Outcome of Secondary Catatonia: A Case Series. Indian J Psychol Med [Internet]. 2024 Mar 27;46(2):178–80. Available from: https://journals.sagepub.com/doi/10.1177/02537176231169428
12. Remberk B, Szostakiewicz Ł, Kałwa A, Bogucka-Bonikowska A, Borowska A, Racicka E. What exactly is catatonia in children and adolescents. Psychiatr Pol. 2020 Aug 31;54(4):759–75.
13. Smith AC, Holmes EG. Catatonia: A Narrative Review for Hospitalists. American Journal of Medicine Open. 2023 Dec;10:100059.
14. Terzi C, Timur İ, Çelikkaleli ŞT. The Diagnostic Challenge of Organic Catatonia: A Case of CLN3 Disease Presenting with Severe Neurological and Psychiatric Symptoms. Turkish Journal of Psychiatry. 2025;
15. Dagra A, Lyerly M, Lucke-Wold B. Encephalitis and Meningitis: Indications for Intervention. Clin Res. 2023 Apr 26;4(1).
16. Beed M, Wong C, Dineen RA, Berry L, Brindley PG. Infectious meningitis and encephalitis: A primer for acute care practitioners. J Intensive Care Soc. 2026 Apr 6. doi:10.1177/17511437261437982
17. Raemy S, Casanova C, Baldan R, Barreto E, Tande AJ, Endimiani A, et al. Penicillin-Susceptible Streptococcus pneumoniae Meningitis in Adults: Does the Ceftriaxone Dosing Matter? Antibiotics. 2023 May 9;12(5):878.
18. Madireddy S, Mangat R. Toxoplasmosis. StatPearls. 2024 Oct 14;
19. Robbins-Welty GA, Gensler L, Kalivas B, Wilson JE, Smith JR, Lindenfeld P, et al. Catatonia in the medically ill and dying: a review for palliative care clinicians. Ann Palliat Med. 2025 Dec;14(6):600–16. doi:10.21037/apm-25-76
20. ASAN Ö. Catatonia : Clinical Features and treatment. Psikiyatride Güncel Yaklaşımlar. 2019 Sep 30;11(3):257–70.
21. Rogers JP, Zandi MS, David AS. The diagnosis and treatment of catatonia. Clinical Medicine. 2023 May;23(3):242–5. doi:10.7861/clinmed.2023-0113
22. Carthy E. Are benzodiazepines effective in treating catatonia? BJPsych Adv. 2021 Jan 18;27(1):3–8. doi:10.1192/bja.2020.79
23. Pérez-Balaguer A, Sánchez-Rivero I. Electroconvulsive therapy, catatonia, deep vein thrombosis and anticoagulant treatment: a case report. Gen Psychiatr. 2021 Dec;34(6):e100666. doi:10.1136/gpsych-2021-100666
24. Pallanti S, Zohar J, Kasper S, Möller HJ, Hollander E. Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach. J Psychiatr Res. 2024 Feb;170:65–72. doi:10.1016/j.jpsychires.2023.11.042.
25. Bot L, Schotsman B, Oostra E, Hoogendoorn AW, Storosum BWC, Planting CHM, et al. The Effect of Benzodiazepines on Catatonia: A Systematic Review and Meta‐Analysis. Acta Psychiatr Scand. 2026 Apr 20. doi:10.1111/acps.70102
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kristian Wiranata, Irena Aryani Puspowardojo, Alifiati Fitrikasari, Herlina Suryawati, Muchlis Achsan Udji Sofro, Witrie Sutaty MR (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
